2026 NPPES data Ophthalmology Physician NPI 1689921033 MD
Verify on CMS →

TIMOTHY EKHLASSI, MD

Ophthalmology Physician in BELLINGHAM, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
262
Medicare Part D claims · 93 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
53%
generic claims · 47% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$69.18
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: TIMOTHY EKHLASSI, MD is a Ophthalmology Physician ([object Object]) practicing in BELLINGHAM, Washington with a Medicare Part D prescribing footprint of 262 claims across 93 beneficiaries — 47% brand-name prescribing . Industry payments of $69.18 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: TIMOTHY EKHLASSI, MD filed 262 Medicare Part D claims in 2023 across BELLINGHAM, Washington. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

TIMOTHY EKHLASSI, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

TIMOTHY EKHLASSI, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 08/03/2012

NPI 1689921033

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

262 82% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

Specialty distribution in Washington

How Ophthalmology Physician compares to other specialties among Washington providers

Washington providers

Ophthalmology Physician share within Washington

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Washington

Specialty board-certification context

Estimated specialty board-certified rate — Ophthalmology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ophthalmology Physician ABMS/AOA estimate

Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TIMOTHY EKHLASSI, MD is a Ophthalmology Physician provider practicing in BELLINGHAM, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1689921033. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

TIMOTHY EKHLASSI, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 3125 HOWE PL STE 101, BELLINGHAM, WA, 98226, with a listed phone of (360) 647-7750. NPI 1689921033 was issued on 08/03/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what EKHLASSI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 262 prescription claims written by this provider, covering 93 Medicare beneficiaries and totaling roughly $33K in drug spend, split 47% brand-name and 53% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3125 HOWE PL STE 101
BELLINGHAM, WA 98226

Provider Details

NPI 1689921033
Specialty Ophthalmology Physician
Credentials MD
Gender Male
NPI Issued 08/03/2012

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TIMOTHY EKHLASSI, MD. Source: openpaymentsdata.cms.gov.

Total received

$69

Largest payer

Glaukos Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to TIMOTHY EKHLASSI, MD. To verify TIMOTHY EKHLASSI, MD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

TIMOTHY EKHLASSI, MD — brand share 47.0%
Specialty average (est.)

47% brand-name claims vs 53% generic, on 262 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

262
Total Claims
$33K
Total Drug Cost
93
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
352
Total Day Supply
8,782
Brand vs Generic
47% brand / 53% generic
Brand Drug Cost
$29K
Generic Drug Cost
$4K

Patient Demographics

Average Patient Age
75.3 years
Avg HCC Risk Score
1.01
Gender Split
72% female / 28% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
74
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
45
Erythromycin
Erythromycin Base
16
Brinzolamide
15
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
15
Prednisolone Acetate
15
Xiidra
Lifitegrast
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How TIMOTHY EKHLASSI, MD fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

TIMOTHY EKHLASSI, MD's 262 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as EKHLASSI.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is TIMOTHY EKHLASSI, MD's specialty?
TIMOTHY EKHLASSI, MD specializes in Ophthalmology Physician and practices in BELLINGHAM, Washington. Credentials: MD.
How much does TIMOTHY EKHLASSI, MD prescribe under Medicare Part D?
In 2023, TIMOTHY EKHLASSI, MD wrote 262 Medicare Part D claims totaling $33K in drug costs for 93 beneficiaries.
Where is TIMOTHY EKHLASSI, MD located?
TIMOTHY EKHLASSI, MD is located at 3125 HOWE PL STE 101, BELLINGHAM, WA, 98226. Phone: (360) 647-7750.
What is TIMOTHY EKHLASSI, MD's NPI number?
TIMOTHY EKHLASSI, MD's National Provider Identifier (NPI) is 1689921033, issued on 08/03/2012.
Does TIMOTHY EKHLASSI, MD prescribe more brand-name or generic drugs?
TIMOTHY EKHLASSI, MD's prescribing is 47% brand-name and 53% generic drugs by claim count, with $29K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does TIMOTHY EKHLASSI, MD prescribe most often?
Based on 2023 Medicare Part D data, TIMOTHY EKHLASSI, MD's most frequently prescribed drugs include Latanoprost, Neomycin-Polymyxin-Dexameth, Erythromycin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TIMOTHY EKHLASSI, MD accept Medicare?
TIMOTHY EKHLASSI, MD appears in CMS Medicare data with 262 Part D claims and 93 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TIMOTHY EKHLASSI, MD's credentials?
TIMOTHY EKHLASSI, MD's NPI is 1689921033 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology